A citation-based method for searching scientific literature


List of co-cited articles
154 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease.
Thomas Nyström, Mark K Gutniak, Qimin Zhang, Fan Zhang, Jens Juul Holst, Bo Ahrén, Ake Sjöholm. Am J Physiol Endocrinol Metab 2004
482
23

Biology of incretins: GLP-1 and GIP.
Laurie L Baggio, Daniel J Drucker. Gastroenterology 2007
23

PLASMA INSULIN RESPONSE TO ORAL AND INTRAVENOUS GLUCOSE ADMINISTRATION.
H ELRICK, L STIMMLER, C J HLAD, Y ARAI. J Clin Endocrinol Metab 1964
663
17

Effects of glucagon-like peptide-1 in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusion.
Lazaros A Nikolaidis, Sunil Mankad, George G Sokos, Glen Miske, Ankur Shah, Dariush Elahi, Richard P Shannon. Circulation 2004
642
17

Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6).
John B Buse, Julio Rosenstock, Giorgio Sesti, Wolfgang E Schmidt, Eduard Montanya, Jason H Brett, Marcin Zychma, Lawrence Blonde. Lancet 2009
17



The glucagon-like peptide 1 analog liraglutide reduces TNF-α-induced oxidative stress and inflammation in endothelial cells.
Aya Shiraki, Jun-ichi Oyama, Hiroshi Komoda, Machiko Asaka, Aiko Komatsu, Masashi Sakuma, Kazuhisa Kodama, Yoshiko Sakamoto, Norihiko Kotooka, Tetsuaki Hirase,[...]. Atherosclerosis 2012
165
17

GLP-1R agonist liraglutide activates cytoprotective pathways and improves outcomes after experimental myocardial infarction in mice.
Mohammad Hossein Noyan-Ashraf, M Abdul Momen, Kiwon Ban, Al-Muktafi Sadi, Yu-Qing Zhou, Ali M Riazi, Laurie L Baggio, R Mark Henkelman, Mansoor Husain, Daniel J Drucker. Diabetes 2009
391
17

Similar elimination rates of glucagon-like peptide-1 in obese type 2 diabetic patients and healthy subjects.
T Vilsbøll, H Agersø, T Krarup, J J Holst. J Clin Endocrinol Metab 2003
301
17

Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials.
Tina Vilsbøll, Mikkel Christensen, Anders E Junker, Filip K Knop, Lise Lotte Gluud. BMJ 2012
505
17

The role of neuropeptide Y in energy homeostasis.
Adam P Chambers, Stephen C Woods. Handb Exp Pharmacol 2012
23
11


Synthetic therapeutic peptides: science and market.
Patrick Vlieghe, Vincent Lisowski, Jean Martinez, Michel Khrestchatisky. Drug Discov Today 2010
789
11

Engineering pro-angiogenic peptides using stable, disulfide-rich cyclic scaffolds.
Lai Y Chan, Sunithi Gunasekera, Sonia T Henriques, Nathalie F Worth, Sarah-Jane Le, Richard J Clark, Julie H Campbell, David J Craik, Norelle L Daly. Blood 2011
134
11

Conus venoms: a rich source of novel ion channel-targeted peptides.
Heinrich Terlau, Baldomero M Olivera. Physiol Rev 2004
653
11

Chemical re-engineering of chlorotoxin improves bioconjugation properties for tumor imaging and targeted therapy.
Muharrem Akcan, Mark R Stroud, Stacey J Hansen, Richard J Clark, Norelle L Daly, David J Craik, James M Olson. J Med Chem 2011
64
11

Cyclotides as a basis for drug design.
David J Craik, Joakim E Swedberg, Joshua S Mylne, Masa Cemazar. Expert Opin Drug Discov 2012
67
11

The engineering of an orally active conotoxin for the treatment of neuropathic pain.
Richard J Clark, Jonas Jensen, Simon T Nevin, Brid P Callaghan, David J Adams, David J Craik. Angew Chem Int Ed Engl 2010
202
11


Engineering stabilized vascular endothelial growth factor-A antagonists: synthesis, structural characterization, and bioactivity of grafted analogues of cyclotides.
Sunithi Gunasekera, Fiona M Foley, Richard J Clark, Lillian Sando, Louis J Fabri, David J Craik, Norelle L Daly. J Med Chem 2008
122
11

Orally active peptidic bradykinin B1 receptor antagonists engineered from a cyclotide scaffold for inflammatory pain treatment.
Clarence T T Wong, Dewi K Rowlands, Chi-Hang Wong, Theodore W C Lo, Giang K T Nguyen, Hoi-Yeung Li, James P Tam. Angew Chem Int Ed Engl 2012
134
11


Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapies.
Michael Elashoff, Aleksey V Matveyenko, Belinda Gier, Robert Elashoff, Peter C Butler. Gastroenterology 2011
536
11

Sequential intensification of metformin treatment in type 2 diabetes with liraglutide followed by randomized addition of basal insulin prompted by A1C targets.
J Hans DeVries, Stephen C Bain, Helena W Rodbard, Jochen Seufert, David D'Alessio, Anne B Thomsen, Marcin Zychma, Julio Rosenstock. Diabetes Care 2012
122
11


Glucagon-like peptide-1 7-36: a physiological incretin in man.
B Kreymann, G Williams, M A Ghatei, S R Bloom. Lancet 1987
11

Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label study.
John B Buse, Michael Nauck, Thomas Forst, Wayne H-H Sheu, Sylvia K Shenouda, Cory R Heilmann, Byron J Hoogwerf, Aijun Gao, Marilyn K Boardman, Mark Fineman,[...]. Lancet 2013
335
11

Identification and actions of gastric inhibitory polypeptide.
J C Brown, J R Dryburgh, S A Ross, J Dupré. Recent Prog Horm Res 1975
226
11

Inhibition of monocyte adhesion to endothelial cells and attenuation of atherosclerotic lesion by a glucagon-like peptide-1 receptor agonist, exendin-4.
Masayuki Arakawa, Tomoya Mita, Kosuke Azuma, Chie Ebato, Hiromasa Goto, Takashi Nomiyama, Yoshio Fujitani, Takahisa Hirose, Ryuzo Kawamori, Hirotaka Watada. Diabetes 2010
346
11


A GLP-1 receptor agonist liraglutide inhibits endothelial cell dysfunction and vascular adhesion molecule expression in an ApoE-/- mouse model.
Tracey Gaspari, HongBin Liu, Iresha Welungoda, Yunshan Hu, Robert E Widdop, Lotte B Knudsen, Richard W Simpson, Anthony E Dear. Diab Vasc Dis Res 2011
113
11


The structure and function of G-protein-coupled receptors.
Daniel M Rosenbaum, Søren G F Rasmussen, Brian K Kobilka. Nature 2009
11

Fatty acid receptors as new therapeutic targets for diabetes.
Geetha Vani Rayasam, Vamshi Krishna Tulasi, Joseph Alex Davis, Vinay S Bansal. Expert Opin Ther Targets 2007
80
11

GPCR modulation by RAMPs.
Debbie L Hay, David R Poyner, Patrick M Sexton. Pharmacol Ther 2006
182
11

Role of CXCR4 in HIV infection and its potential as a therapeutic target.
Tsutomu Murakami, Naoki Yamamoto. Future Microbiol 2010
15
13

G protein-coupled receptor kinases: more than just kinases and not only for GPCRs.
Eugenia V Gurevich, John J G Tesmer, Arcady Mushegian, Vsevolod V Gurevich. Pharmacol Ther 2012
269
11

The metabotropic glutamate receptor 5 antagonist MPEP and the mGluR2 agonist LY379268 modify disease progression in a transgenic mouse model of Huntington's disease.
Johannes Schiefer, Arne Sprünken, Christiane Puls, Hans-Gerd Lüesse, Anna Milkereit, Eva Milkereit, Verena Johann, Christoph M Kosinski. Brain Res 2004
80
11

Pharmacogenomics of G protein-coupled receptor signaling: insights from health and disease.
Miles D Thompson, David E C Cole, Pedro A Jose. Methods Mol Biol 2008
30
11

GRKs and beta-arrestins: roles in receptor silencing, trafficking and signaling.
Eric Reiter, Robert J Lefkowitz. Trends Endocrinol Metab 2006
467
11

Refining efficacy: allosterism and bias in G protein-coupled receptor signaling.
Louis M Luttrell, Terry P Kenakin. Methods Mol Biol 2011
62
11

G-protein-coupled receptors and signaling networks: emerging paradigms.
M J Marinissen, J S Gutkind. Trends Pharmacol Sci 2001
734
11

Fine-tuning of GPCR activity by receptor-interacting proteins.
Stefanie L Ritter, Randy A Hall. Nat Rev Mol Cell Biol 2009
320
11

Cannabinoids for the treatment of inflammation.
John C Ashton. Curr Opin Investig Drugs 2007
62
11

A designer network coordinating bovine artificial insemination by ovulation-triggered release of implanted sperms.
Christian Kemmer, David Andreas Fluri, Ulrich Witschi, Alain Passeraub, Andreas Gutzwiller, Martin Fussenegger. J Control Release 2011
54
11

Pharmaceutically controlled designer circuit for the treatment of the metabolic syndrome.
Haifeng Ye, Ghislaine Charpin-El Hamri, Katharina Zwicky, Matthias Christen, Marc Folcher, Martin Fussenegger. Proc Natl Acad Sci U S A 2013
64
11



Mechanisms of action of glucagon-like peptide 1 in the pancreas.
Máire E Doyle, Josephine M Egan. Pharmacol Ther 2007
396
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.